China

Home / China / Latest

Sinopharm applies for vaccine market approval

chinadaily.com.cn | Updated: 2020-11-25 14:29

Share

Share - WeChat

A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd (Sinopharm) in Beijing, capital of China, April 10, 2020. [Photo/Xinhua]

Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.

Photo

Tiger and lion cubs debut at Chongqing park event

Light-rail driver training session for Kazakh trainees held in Tianjin

Metro network grows in Shijiazhuang, North China

Students explore relic restoration in Xinjiang

Pic story of horse trainer in Xinjiang

Wuxi school introduces reclining chairs for student naps

Latest

State Council News

China to launch K visa for young science, technology talents

Exclusive

One-China principle: From the UN to global consensus

People's call for reunion

Same-name villages across the Strait share ancestral roots

Newsmaker

Naval gunner's attention to detail improves hit rates

Animals get a second chance at life

Ten photos you don't wanna miss

Ten photos from across China: Aug 29 – Sept 4

Special Coverage

Celebrating 70 years of progress in Xinjiang

Stories across the Strait

BACK TO THE TOP

English

中文

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349

About China Daily

Advertise on Site

Expat Employment

FOLLOW US